Common Shares Outstanding: The number of class A shares currently held by investors.
Passage Bio, Inc. (PASG) had Common Shares Outstanding of 54.94M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-102.06M |
|
-- |
|
-- |
|
$108.39M |
|
$-108.39M |
|
$6.33M |
|
$-102.06M |
|
$-102.06M |
|
$-102.06M |
|
$-102.06M |
|
$-102.06M |
|
$-102.06M |
|
$-108.39M |
|
$-106.70M |
|
54.74M |
|
54.74M |
|
$-1.86 |
|
$-1.86 |
|
Balance Sheet Financials | |
$117.96M |
|
$15.29M |
|
$32.59M |
|
$150.54M |
|
$16.34M |
|
-- |
|
$22.92M |
|
$39.26M |
|
$111.28M |
|
$111.28M |
|
$111.28M |
|
Common Shares Outstanding |
54.94M |
Cash Flow Statement Financials | |
$-78.26M |
|
$65.24M |
|
$0.14M |
|
$34.60M |
|
$21.71M |
|
$-12.89M |
|
$10.92M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
7.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-78.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-91.71% |
|
-91.71% |
|
-67.80% |
|
-91.71% |
|
$2.03 |
|
$-1.43 |
|
$-1.43 |